期刊文献+

国产坎地沙坦酯对原发性高血压治疗6个月的有效及安全性观察

An 6-month open trial on Effects and safety of candesartan in patients with hypertension
下载PDF
导出
摘要 目的观察国产坎地沙坦酯治疗高血压6个月中的有效性、安全性。方法选择45例18~65岁的中国轻、中度原发性高血压患者,经2周停服降压药后,口服坎地沙坦8mg,每天1次;4周后,若坐位舒张压(SiDBP)≥90mmHg时剂量加倍至24周。分别在用药后第2、4、6、8、12、16、20及24周末随访,观察其疗效和安全性。结果①坎地沙坦8~16mg/d,服药后第2、4、6、8、12、16、20及24周时,坐、立位舒张压、收缩压均明显下降(P均=0.0001)。②不良反应6.7%(头晕2例、头痛1例),且程度较轻。结论8~16mg/d坎地沙坦治疗原发性高血压6个月的疗效及耐受性较好。 Objective To evaluate the effect and safety of candesartan cilexitil made in China in patients with mild and moderate hypertension. Methods After 2-weeks wash-out, 45 patients with siting diastolic blood pressure (SiDBP) 95 - 115 mmHg received candesartan 8 mg QD for 4 weeks ;then ,if SiDBP ≥90 mm Hg, the dosage would be double till to 24 week treatment. All patients visited at 0, 2^nd ,4^th ,6^th, 8^th, 12^th, 16^th ,20^th, and 24^th wee respectively. Results ①The mean of SiDBP , SiSBP , standing DBP(StDBP) and StSBP all decreased significantly from baseline At 2^nd ,4^th ,6^th, 8^th, 12^th, 16^th ,20^th, and 24^th week of treatment with candesartan cilexitil 8-16mg once daily( all P = 0. 0001 ).② There were a few and mild advent reactions(6.7% ) during 6 months . Conclusion Administration of candesartan cilexitil orally 8- 16mg once daily appears to be a well-tolerated, safe, and effective antihvpertensive treatment.
出处 《中国医刊》 CAS 2005年第11期31-32,共2页 Chinese Journal of Medicine
关键词 坎地沙坦酯 国产 高血压 有效性 安全性 Candesartan Cilexitil Hypertension effectiveness safety
  • 相关文献

参考文献5

  • 1Fuchs B, Breithaupt-Grogler K, Belz GG,et al. Comparative pharmacodynamics and pharmacokinetics of candesartan and losartan in man [J]. J Pharm Pharmacol,2000,52(9): 1075 - 1083.
  • 2Franke H. AntiHypertensive effects of cadesartan cilexetil,enalapril and placbo are of equivalent efficacy in patients with mild to moderate hypertension [J]. J Human Hypertens, 1997,11 (suppl 2):S61 - S62.
  • 3Ianchotti A, Ombomi S, Biagio C, et al. Candesartan cilexetil and enalapril are if equivalent efficacy in patients with mild to moderate hypertension [J]. J Human Hypertens, 1997,11 (suppl 2): S57- 59.
  • 4Zuschke CA, Keys I, Munger MA ,et al. Candesartan cilexetil:comparison of once-daily versus twice-daily administration for systemic hypertension. Candesartan Cilexetil Study Investigators[J]. Clin Ther,1999,21 (3): 464 - 474.
  • 5Easthope SE, Jarvis B. Candesartan cilexetil: an update of its use in essential hypertension[J]. Drugs, 2002,62 (8):1253 - 1287.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部